HOME >> MEDICINE >> NEWS
Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference

Napa, CA (May 21, 2007) -- Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD). "Nebulized Formoterol is an Effective Bronchodilator and Improves the Quality of Life for COPD Patients" presented results of the Phase III pivotal clinical study, a 12-week randomized, double-blind, double-dummy, placebo- and active-controlled trial. The trial found that Perforomist Inhalation Solution, a twice-daily, long-acting beta2-agonist (LABA):

  • provided rapid bronchodilation that lasted a full 12 hours,
  • enabled patients to use less rescue medication,
  • maintained improvements in lung function with no evidence of tolerance (tachyphylaxis) over the 12-week period, and
  • improved the lung function and quality of life of patients compared to placebo.

No significant difference in efficacy was observed over 12 weeks of treatment between Perforomist Inhalation Solution and the active comparator, dry powder Foradil.

A separate presentation given at ATS detailed the safety results of the same trial. "Safety Profile of Formoterol Fumarate Delivered by Nebulization to COPD Patients" found that Perforomist Inhalation Solution was well tolerated, had a safety profile similar to that of Foradil, and resulted in fewer COPD exacerbations than was seen with placebo. Taken together, the data from these two presentations demonstrate that Perforomist Inhalation Solution will provide a new, safe and effective therapeutic option for long-term maintenance treatment of COPD.

Nicholas J. Gross, MD, PhD, an expert on lung diseases, particularly COPD, was the Principal Investigator for the Phase III pivo
'"/>

Contact: Harriet Ullman
harriet.ullman@fkhealth.com
617-577-8110
Feinstein Kean Healthcare
21-May-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical guidelines for blood conservation during cardiac procedures developed
6. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
7. Clinical trial coordinators need more financial conflict-of-interest training
8. Clinical studies evaluate potential treatments for mouth ulcers
9. NIH names Clinical Trial Units for the Microbicide Trials Network
10. Clinical Trials Units selected for newly restructured HIV/AIDS research networks
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/18/2019)... BEVERLY HILLS, Calif. (PRWEB) , ... April 18, ... ... at an upscale dental practice in Beverly Hills that offers a full menu ... his superior cosmetic treatments and sought-after expertise in biomimetic dentistry, which relies on ...
(Date:4/18/2019)... ... 18, 2019 , ... As cannabis users prepare to celebrate ... The study—which considers consumers’ perceptions of, attitudes about, and experiences within the nascent ... what kinds of products consumers want to see. , Indeed, as TrendSource’s Director ...
(Date:4/17/2019)... South Korea (PRWEB) , ... April 17, 2019 ... ... Consulting visited SHIN SUNG TK, a Korean company located in Gwangju, Korea, and ... IoT with its own patent. The two companies were in discussion of a ...
(Date:4/17/2019)... ... April 17, 2019 , ... On May 3, Kyle ... back-to-back IMSA victories. , During the IMSA Continental Tire SportsCar Challenge race in 2018, ... and a last-minute scare to drive their #60 KohR Motorsports / Roush ...
(Date:4/17/2019)... AVERILL PARK, N.Y. (PRWEB) , ... April 17, ... ... of The American Meditation Institute will announce the formulation of the Yoga Science ... physicians and other health care providers, October 22-26, 2019 at the Cranwell Resort ...
Breaking Medicine News(10 mins):
(Date:4/19/2019)... ... April 19, 2019 , ... Want to live longer and look ... Dermatology PC , “but we still have work to do so that people understand ... evidence is overwhelming: According to the American Academy of Dermatology, one session in a ...
(Date:4/19/2019)... (PRWEB) , ... April 19, 2019 , ... ... global pharmaceutical regulatory agencies at the 2019 PDA Biosimilars and Vaccines Conference: ... May 9 – 10, 2019. The confirmed regulatory speakers are: , Anissa ...
(Date:4/19/2019)... , ... April 18, 2019 , ... Janice F. Whaley has a vision. A ... second chance at life. Ms. Whaley has focused her entire career on the mission ... through organ and tissue donation for transplantation. , There is a sad reality for the ...
Breaking Medicine Technology:
Cached News: